Optimal Time Interval between Neoadjuvant Platinum-Based Chemotherapy and Interval Debulking Surgery in High-Grade Serous Ovarian Cancer

Optimal Time Interval between Neoadjuvant Platinum-Based Chemotherapy and Interval Debulking Surgery in High-Grade Serous Ovarian Cancer

Background: There is limited data on the optimal time interval between the last dose of neoadjuvant chemotherapy (NACT) and interval debulking surgery (IDS) in high-grade serous ovarian carcinoma (HGSC). Methods: We retrospectively identified patients with stage IIIC/IV HGSC who received NACT follow...

Full description

Bibliographic Details
Main Authors: Angeliki Andrikopoulou, Charalampos Theofanakis, Christos Markellos, Maria Kaparelou, Konstantinos Koutsoukos, Kleoniki Apostolidou, Nikolaos Thomakos, Dimitrios Haidopoulos, Alexandros Rodolakis, Meletios-Athanasios Dimopoulos, Flora Zagouri, Michalis Liontos
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Cancers
Subjects:
ovarian cancer
IDS
time interval
cytoreductive surgery
neoadjuvant
progression-free survival
Online Access:https://www.mdpi.com/2072-6694/15/13/3519

Internet

https://www.mdpi.com/2072-6694/15/13/3519

Similar Items